Page last updated: 2024-08-22

cladribine and Hemorrhagic Thrombocythemia

cladribine has been researched along with Hemorrhagic Thrombocythemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertele', V; Garattini, S; Gerardi, C; Joppi, R1
Azagury, M; Duboucher, C; Flandrin, G; Martelli, JM; Morcelet, M1

Reviews

1 review(s) available for cladribine and Hemorrhagic Thrombocythemia

ArticleYear
Letting post-marketing bridge the evidence gap: the case of orphan drugs.
    BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate

2016

Other Studies

1 other study(ies) available for cladribine and Hemorrhagic Thrombocythemia

ArticleYear
Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:6

    Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Hydroxyurea; Leukemia, Hairy Cell; Male; Thrombocythemia, Essential

2003